GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Deferred Tax

Helixmith Co (XKRX:084990) Deferred Tax : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Helixmith Co's change in deferred tax for the three months ended in Sep. 2024 was ₩0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

Helixmith Co Deferred Tax Historical Data

The historical data trend for Helixmith Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Deferred Tax Chart

Helixmith Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 57.45 -100.02

Helixmith Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Helixmith Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helixmith Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Helixmith Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Helixmith Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Deferred Tax
Comparable Companies
XKRX:214260 XKRX:138610 XKRX:078160 XKRX:235980 XKRX:314130 XKRX:174900 XKRX:321550 XKRX:226950 XKRX:278650 XKRX:046210 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826
Website
https://www.helixmith.com
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines